Tumour-infiltrating FOXP3+ lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer
Open Access
- 20 November 2012
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 108 (1), 155-162
- https://doi.org/10.1038/bjc.2012.524
Abstract
Background: Methods: Results: Conclusion:This publication has 47 references indexed in Scilit:
- Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological gradeHistopathology, 2011
- In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunctionProceedings of the National Academy of Sciences of the United States of America, 2010
- A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancerOncology Reports, 2009
- Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic targetLaboratory Investigation, 2008
- Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancerBreast Cancer Research and Treatment, 2008
- FOXP3 modifies the phenotypic and functional properties of regulatory T cellsNature Reviews Immunology, 2007
- Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine productionInternational Immunology, 2007
- Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late RelapseJournal of Clinical Oncology, 2006
- X-TileClinical Cancer Research, 2004
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survivalNature Medicine, 2004